Month: May 2024

Q1 2024 revenue Strong start of the year anddynamic commercial momentumTotal revenue growth of +19.6% in constant currencies, reaching € 40.9 million Solid commercial traction with existing clients and new logos Further product enhancements and third-party industry analysts’ recognition 2024 objectives confirmedParis, France, May 21, 2024 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, announces today its revenue for Q1 2024. Total revenue amounted to € 40.9 million, up by +18.5% in current currencies, mainly led by the continued success of the Group’s market-leading SaaS platform. In constant currencies, total revenue growth reached +19.6% (+€6.8 million), in line with the trajectory expected for the year and the 2024 objective of approximately 19.5% revenue growth in constant currencies....

The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting1 Approximately 40% of people with HR-positive breast cancer have a PIK3CA mutation and often face poorer prognosis and resistance to endocrine treatment2,3 This is the 29th Breakthrough Therapy Designation for Roche’s oncology portfolio, a testament to our enduring ambition to deliver transformative medicines for patients4Basel, 21 May 2024 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with palbociclib (Ibrance®) and fulvestrant, for the treatment of adult...

Ad hoc announcement pursuant to Art. 53 LRJean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of Directors Mathieu Simon to stand for re-election to the Board – taking on the role of Vice-Chairman and Lead Independent Director André C. Muller, current CFO of Idorsia, to take over the role of CEO as of June 13, 2024Allschwil, Switzerland – May 21, 2024Idorsia Ltd (SIX: IDIA) today announced changes to the Idorsia Executive Committee (IEC) and will propose changes in membership of the Board of Directors at the upcoming Annual General Meeting of shareholders (AGM), to be held on June 13, 2024. Jean-Paul Clozel, 69, has decided to retire from his role as Chief Executive Officer (CEO) of Idorsia and stand for election as Chairman of the Board of Directors at this year’s AGM. Jean-Paul has served as CEO of Idorsia...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – May 21, 2024 Idorsia Ltd (SIX: IDIA) today announced its financial results for the first quarter of 2024. Business highlightsViatris collaboration: Global research and development collaboration, focused on the development and commercialization of two innovative compounds, selatogrel and cenerimod.Commercial highlightsQUVIVIQ™ (daridorexant): Total net sales of CHF 10 million in Q1 2024. QUVIVIQ in the US: Citizens petition to deschedule the DORA class progressing. QUVIVIQ in Europe: Further launches, including France, provide a solid base to increase European sales in 2024.Pipeline highlightsTRYVIO™ (aprocitentan): Approved by the US FDA in March 2024. JERAYGO™ (aprocitentan): Recommended for approval in Europe. Daridorexant: Phase 3 study...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – May 21, 2024Idorsia Ltd (SIX: IDIA) today announced its financial results for the full year of 2023. Business highlightsSale of Idorsia Asia-Pacific operations (excluding China): Sold to Nxera Pharma (previously known as Sosei Heptares) for a total consideration of CHF 400 million in July 2023. Cost reduction initiative: Delivering a 50% reduction in fixed cost at Swiss headquarters fully effective in early 2024. Aprocitentan: Worldwide rights reacquired from Janssen for a conditional consideration of CHF 306 million in September 2023.Commercial highlightsQUVIVIQ™ (daridorexant): Total net sales of CHF 31 million in 2023. QUVIVIQ: Expanded access and availability in the US, Canada and across Europe.Financial highlights FY 2023Net revenue FY 2023 at CHF...

PINE MOUNTAIN, Georgia, May 20, 2024 (GLOBE NEWSWIRE) — Parks! America, Inc. (OTCPink: PRKA) (“Parks! America” or the “Company”), a leading operator of regional safari parks in the United States, today issued an open letter to the Company’s shareholders outlining the clear choice hanging in the balance at its annual meeting of shareholders scheduled for June 6, 2024. Dear Parks! America Shareholders, After five months of wasting your time and damaging Parks! America by causing the diversion of money and management time, on May 8th the principals of Focused Compounding (“FC”) finally revealed their real “plan”: to liquidate the assets of the Company. It is difficult to tell if this was their plan all along or just another attempt at deploying business management buzzwords to further their dream of conducting a proxy fight with a...

Volvo On DemandVolvo Trucks North America and Volvo Financial Services are collaborating on Volvo on Demand, a joint project to accelerate battery-electric vehicle adoption and redefine the Truck-as-a-Service (TaaS) business model using 25 Class 8 Volvo VNR Electric trucks.Greensboro, N.C., May 20, 2024 (GLOBE NEWSWIRE) — Volvo Trucks North America (VTNA) and Volvo Financial Services (VFS) have joined forces to form Volvo on Demand, a collaborative initiative to change and lead the industry in the Truck-as-a-Service (TaaS) business model. Using 25 Class 8 Volvo VNR Electric trucks, Volvo on Demand was designed as an innovative solution to simplify the acquisition and reduce the major upfront investment in battery-electric vehicles. Volvo on Demand provides qualified customers with flexible term options as short as 12 months...

Purpose designed and built for autonomy; the fully redundant truck will enable autonomous transportVolvo VNL Autonomous Truck (Front View)Volvo Autonomous Solutions (V.A.S.) unveiled Volvo’s first-ever production ready autonomous truck at the Advanced Clean Transportation (ACT) Expo May 20 in Las Vegas.Volvo VNL Autonomous Truck (Side View)The Volvo VNL Autonomous Truck brings together Volvo’s commercial vehicle expertise with industry-leading autonomous driving technology from Aurora Innovation.Greensboro, N.C., May 20, 2024 (GLOBE NEWSWIRE) — Volvo Autonomous Solutions (V.A.S.) today unveiled Volvo’s first-ever production ready autonomous truck at the Advanced Clean Transporation (ACT) Expo in Las Vegas. The Volvo VNL Autonomous brings together Volvo’s commercial vehicle expertise with industry-leading autonomous...